Concepedia

Publication | Open Access

<scp>COVID</scp>‐19 antibody screening with <scp>SARS‐CoV</scp>‐2 red cell kodecytes using routine serologic diagnostic platforms

19

Citations

25

References

2021

Year

Abstract

C19-kodecytes are viable for use as serologic reagent red cells for the detection of SARS-CoV-2 antibody with routine blood antibody screening equipment.

References

YearCitations

Page 1